European Heart Journal Supplements最新文献_第10页

Complementary role of governments, non-governmental organizations, industry, and medical societies in expanding bradycardia therapy access. 政府、非政府组织、行业和医学协会在扩大获得心动过缓治疗方面的互补作用。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-12-01 DOI: 10.1093/eurheartjsupp/suad124

Jitendra Singh Makkar, Goran Milasinovic, Chi Keong Ching

{"title":"Complementary role of governments, non-governmental organizations, industry, and medical societies in expanding bradycardia therapy access.","authors":"Jitendra Singh Makkar, Goran Milasinovic, Chi Keong Ching","doi":"10.1093/eurheartjsupp/suad124","DOIUrl":"10.1093/eurheartjsupp/suad124","url":null,"abstract":"As the aging population continues to grow, so has the incidence of cardiovascular diseases, including bradycardia, with much of the burden falling on low- and middle-income countries (LMICs). Pacemaker therapy remains the only guideline-recommended therapy for symptomatic bradycardia, but due to the cost and expertise required for pacemaker implants, patients in LMICs have less access to pacemaker therapies. However, with the concerted effort of organizations (governments, non-governmental organizations, industry, and medical societies) strides can continue to be made in improving access to care. Governments play a role in extending health coverage to its citizens and improving their physical and digital healthcare infrastructure. Non-governmental organizations promote access and awareness through charity and advocacy programs. Industries can continue innovating technology that is both affordable and accessible. Medical societies provide guidelines for treatment and necessary educational and networking opportunities for physicians who serve in LMICs. All of these organizations have individual responsibilities and goals in expanding access to bradycardia therapy, which can be more easily realized by their continued collaboration.","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"25 Suppl H","pages":"H22-H26"},"PeriodicalIF":1.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138477118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Conduction system pacing: overview, definitions, and nomenclature. 传导系统节奏:概述、定义和命名法。

IF 1.7 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad114

Marek Jastrzebski, Gopi Dandamudi, Haran Burri, Kenneth A Ellenbogen

{"title":"Conduction system pacing: overview, definitions, and nomenclature.","authors":"Marek Jastrzebski, Gopi Dandamudi, Haran Burri, Kenneth A Ellenbogen","doi":"10.1093/eurheartjsupp/suad114","DOIUrl":"10.1093/eurheartjsupp/suad114","url":null,"abstract":"Pacing from the right ventricle is associated with an increased risk of development of congestive heart failure, increases in total and cardiac mortality, and a worsened quality of life. Conduction system pacing has become increasingly realized as an alternative to right ventricular apical pacing. Conduction system pacing from the His bundle and left bundle branch area has been shown to provide physiologic activation of the ventricle and may be an alternative to coronary sinus pacing. Conduction system pacing has been studied as an alternative for both bradycardia pacing and for heart failure pacing. In this review, we summarize the clinical results of conduction system pacing under a variety of different clinical settings. The anatomic targets of conduction system pacing are illustrated, and electrocardiographic correlates of pacing from different sites in the conduction system are defined. Ultimately, clinical trials comparing conduction system pacing with standard right ventricular apical pacing and cardiac resynchronization therapy pacing will help define its benefit and risks compared with existing techniques.","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"25 Suppl G","pages":"G4-G14"},"PeriodicalIF":1.7,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134648677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Frontiers in conduction system pacing: treatment of long PR in patients with heart failure. 传导系统起搏的前沿:心力衰竭患者长PR的治疗。

IF 1.7 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad116

Nandita Kaza, Daniel Keene, Pugazhendhi Vijayaraman, Zachary Whinnett

{"title":"Frontiers in conduction system pacing: treatment of long PR in patients with heart failure.","authors":"Nandita Kaza, Daniel Keene, Pugazhendhi Vijayaraman, Zachary Whinnett","doi":"10.1093/eurheartjsupp/suad116","DOIUrl":"10.1093/eurheartjsupp/suad116","url":null,"abstract":"Patients with heart failure who have a prolonged PR interval are at a greater risk of adverse clinical outcomes than those with a normal PR interval. Potential mechanisms of harm relating to prolonged PR intervals include reduced ventricular filling and also the potential progression to a higher degree heart block. There has, however, been relatively little work specifically focusing on isolated PR prolongation as a therapeutic target. Secondary analyses of trials of biventricular pacing in heart failure have suggested that PR prolongation is both a prognostic marker and a promising treatment target. However, while biventricular pacing offers an improved activation pattern, it is nonetheless less physiological than native conduction in patients with a narrow QRS duration, and thus, may not be the ideal option for achieving therapeutic shortening of atrioventricular delay. Conduction system pacing aims to preserve physiological ventricular activation and may therefore be the ideal method for ventricular pacing in patients with isolated PR prolongation. Acute haemodynamic experiments and the recently reported His-optimized pacing evaluated for heart failure (HOPE HF) Randomised Controlled Trial demonstrates the potential benefits of physiological ventricular pacing on patient symptoms and left ventricular function in patients with heart failure.","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"25 Suppl G","pages":"G27-G32"},"PeriodicalIF":1.7,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134648678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A new era of physiologic cardiac pacing. 生理性心脏起搏的新时代。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad120

Haran Burri, Pugazhendhi Vijayaraman

引用次数: 0

Alternative atrial pacing site to improve cardiac function: focus on Bachmann's bundle pacing. 替代心房起搏部位改善心功能:关注巴赫曼束起搏。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad118

Edmond M Cronin, Natasha Vedage, Carsten W Israel

引用次数: 0

Role of conduction system pacing in ablate and pace strategies for atrial fibrillation. 传导系统起搏在心房颤动消融和起搏策略中的作用。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad119

Roderick Tung, Haran Burri

引用次数: 0

Implant, assessment, and management of conduction system pacing. 传导系统起搏的植入、评估和管理。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad115

Kevin Vernooy, Daniel Keene, Weijian Huang, Pugazhendhi Vijayaraman

引用次数: 1

Personalized accelerated physiologic pacing. 个性化加速生理起搏。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-11-09 eCollection Date: 2023-11-01 DOI: 10.1093/eurheartjsupp/suad117

Markus Meyer, Margaret Infeld, Nicole Habel, Daniel Lustgarten

{"title":"Personalized accelerated physiologic pacing.","authors":"Markus Meyer, Margaret Infeld, Nicole Habel, Daniel Lustgarten","doi":"10.1093/eurheartjsupp/suad117","DOIUrl":"10.1093/eurheartjsupp/suad117","url":null,"abstract":"Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent with a high socioeconomic burden. Pharmacological heart rate lowering was recommended to improve ventricular filling in HFpEF. This article discusses the misperceptions that have resulted in an overprescription of beta-blockers, which in all likelihood have untoward effects on patients with HFpEF, even if they have atrial fibrillation or coronary artery disease as a comorbidity. Directly contradicting the lower heart rate paradigm, faster heart rates provide haemodynamic and structural benefits, amongst which lower cardiac filling pressures and improved ventricular capacitance may be most important. Safe delivery of this therapeutic approach is feasible with atrial and ventricular conduction system pacing that aims to emulate or enhance cardiac excitation to maximize the haemodynamic benefits of accelerated pacing. This conceptual framework was first tested in the myPACE randomized controlled trial of patients with pre-existing pacemakers and preclinical or overt HFpEF. This article provides the background and path towards this treatment approach.","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"25 Suppl G","pages":"G33-G43"},"PeriodicalIF":1.6,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134648680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correction to: Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy. 更正：肥厚型心肌病患者的诊断和预后心电图特征。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-09-18 eCollection Date: 2023-05-01 DOI: 10.1093/eurheartjsupp/suad121

引用次数: 0

Corrigendum to: In pursuit of balance: RAASi and hyperkalemia treatment. 更正：追求平衡：RAASi和高钾血症治疗。

IF 1.6 4区医学

European Heart Journal Supplements Pub Date : 2023-09-15 eCollection Date: 2023-05-01 DOI: 10.1093/eurheartjsupp/suad122

Edoardo Sciatti, Emilia D'Elia, Giulio Balestrieri, Salvatore D'Isa, Attilio Iacovoni, Michele Senni

引用次数: 0